Clinical Trial Update: Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating irinotecan in combination with cyclosporine and phenobarbital in adults with solid tumors or lymphoma; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Small Intestine Cancer
• Solid Tumors

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Irinotecan (Irinotecan)
• Phenobarbital (phenobarbital)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Drug/Agent Toxicity by Tissue/Organ, Lymphoma | Phase 1 | Status: COMPLETED